C

Cardinal Health

Distributes medicines and medical supplies

Principal Validation Engineer

Full-TimeUpdated on 10/23/2026Deadline 12/2/26
$82.1k - $128.9k
Senior, Expert
Bachelor's, Master's
Indianapolis, IN, USA
In Person
Biology & BiotechRegulatory & Quality (Life Sciences)
Company Does Not Provide H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in Engineering, such as Chemical, Mechanical, Electrical, or Biomedical Engineering, or a related scientific discipline such as Chemistry or Biochemistry, is preferred; a master's degree is also preferred.
  • Six to ten years of progressive validation experience in a cGMP pharmaceutical or biotechnology manufacturing environment is preferred.
  • Extensive experience with equipment, process, cleaning, utility, facility, media fill, and computer system validation is preferred.
  • Demonstrated expertise in FDA regulations, including 21 CFR Parts 210, 211, and 820; EMA requirements; ISO standards; and NRC regulations relevant to nuclear pharmaceutical manufacturing is preferred.
  • Ability to manage weight up to 25 pounds.
  • A proven track record of leading significant validation projects and contributing to successful regulatory audits is preferred.
  • Strong analytical, problem-solving, and critical thinking abilities, with a focus on data integrity and statistical analysis.
  • Strong written and verbal communication skills, including the ability to present complex technical information clearly and concisely to diverse audiences.
  • Strong project management skills, including the ability to manage multiple projects simultaneously and drive them to successful completion.
  • Deep understanding of quality systems, including deviations, corrective and preventive actions, and change control, and their integration with validation activities is preferred.
  • Ability to influence and collaborate effectively with stakeholders across departments.
  • Ability to provide technical guidance and mentorship to junior colleagues.
Responsibilities
  • Serve as a subject matter expert for complex process, equipment, cleaning, utility, facility, and computer system validation activities, providing advanced technical guidance for nuclear pharmaceutical manufacturing sites.
  • Lead the planning, execution, and documentation of complex validation projects, ensuring adherence to project timelines, quality standards, and regulatory requirements.
  • Contribute to the development, implementation, and continuous improvement of validation master plans, policies, and procedures, aligning them with industry best practices and evolving regulatory requirements, including cGMP, FDA, EMA, ISO, and NRC requirements.
  • Design, author, execute, and review complex validation protocols, including DQ, IQ, OQ, and PQ, and reports, ensuring scientific soundness, statistical justification, and regulatory compliance.
  • Act as a lead investigator for complex deviations, out-of-specification results, and non-conformances related to validated systems; perform root cause analysis and implement corrective and preventive actions.
  • Contribute to the development and implementation of risk-based validation strategies, including applying Quality by Design principles, to optimize validation efforts and ensure robust process control.
  • Represent the validation department during internal and external regulatory inspections and audits, including FDA, EMA, and NRC inspections, explaining and defending validation strategies and documentation.
  • Collaborate with Manufacturing, Quality Assurance, Engineering, Research and Development, and Regulatory Affairs to integrate validation requirements throughout the product lifecycle.
  • Provide technical guidance and mentorship to less experienced Validation Engineers, supporting their professional development and consistency in validation practices.
  • Evaluate new technologies, equipment, and processes for their impact on the validated state and develop appropriate validation approaches.
  • Monitor industry trends, regulatory changes, and advanced validation methodologies, and integrate relevant updates into the validation program.
  • Apply comprehensive knowledge and a thorough understanding of concepts, principles, and technical capabilities to perform varied tasks and projects.
  • Contribute to the development of policies and procedures as needed.
  • Work on complex projects of large scope and develop innovative technical solutions to difficult problems consistent with organizational objectives.
  • Complete work independently, receiving general guidance on new projects; work is reviewed for the purpose of meeting objectives.
  • Mentor less experienced colleagues as needed.

About the company

Cardinal Health distributes pharmaceuticals and medical products to pharmacies, hospitals, clinics and physician offices, mainly in the United States. Its largest business buys branded, generic and specialty medicines from drugmakers and delivers them to retail chains, independent pharmacies and health systems. The company also makes and sources Cardinal Health brand medical and surgical supplies, runs nuclear pharmacies that prepare radioactive drugs for imaging, and ships home-health supplies directly to patients. It earns most of its revenue from the margin on products it distributes, plus manufacturing, logistics and services for specialty physician practices. Cardinal Health was founded in 1971 and is based in Dublin, Ohio.

Company Size

10,001+

Company Stage

N/A

Total Funding

$270.6M

Headquarters

Dublin, California

Founded

1971

Get referred to Cardinal Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Equity has momentum: in August 2026, Cardinal guided fiscal 2027 EPS growth of 13% to 15%, above its long-term target.
  • Specialty drugs drive profit: brand and specialty medicines lifted pharma segment profit 23% in the year ending June 2026.
  • Cardinal keeps raising its payout: in May 2026, its board lifted the quarterly dividend to $0.5158 per share from $0.5107.

What critics are saying

  • One buyer dominates: CVS Health supplied 28% of Cardinal's fiscal 2026 revenue, and the five largest customers 43%.
  • Opioid bills continue: Cardinal held $4.3 billion for national settlements in June 2026 and paid $374 million in July.
  • Factory jobs are going: Cardinal subsidiary KPR filed in March 2026 to close its Augusta, Georgia plant, cutting 213 jobs.

What makes Cardinal Health unique

  • Cardinal owns specialist doctor networks: its management companies support about 3,000 gastroenterology, urology and other providers in 32 states.
  • Cardinal makes products as well as moving them: its own-brand medical and surgical supplies drive growth in its supplies segment.
  • Cardinal runs nuclear pharmacies: its Nuclear and Precision Health unit prepares radioactive drugs used in medical imaging.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Health Savings Account/Flexible Spending Account
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Short- and Long-term Disability Coverage
  • Paid Parental Leave
  • Wellness Program

Company News

Yahoo Finance
Aug 11th, 2026
Cardinal Health forecasts profit above estimates on specialty drug demand, eyes $1B buyback

Cardinal Health forecast fiscal 2027 profit between $12.40 and $12.60 per share, exceeding analyst expectations of $12.04, driven by strong demand for specialty drugs. The US drug distributor's shares rose over 4% in premarket trading. The company's fourth-quarter adjusted profit of $2.91 per share beat estimates of $2.42. However, total revenue of $63.67 billion missed expectations of $65.03 billion. Cardinal Health is benefiting from rising demand for biosimilars and high-margin medicines treating cancer, rheumatoid arthritis, and autoimmune diseases. Its Pharmaceutical and Specialty Solutions unit saw sales increase 6% to $55.4 billion. Last month, Cardinal purchased AdaptHealth's diabetes business and Strive Medical for approximately $360 million combined. The company also announced $1 billion in planned share repurchases for fiscal 2027.

Healthcare Dive
Jul 21st, 2026
Cardinal Health acquires Strive Medical and AdaptHealth's diabetes unit for $360M to expand home care services

Cardinal Health has agreed to acquire multi-specialty supply company Strive Medical and AdaptHealth's diabetes business for a combined $360 million in cash. The drug distributor said the acquisitions will expand its at-home solutions business, which delivers medical supplies directly to patients. The deals build on Cardinal's recent investments in home care services. The company's at-home unit generated $1.7 billion in revenue during its third quarter this year, helping grow profit by 34% year over year. Cardinal expects the acquisitions to be earnings accretive within a year of closing. AdaptHealth's diabetes unit serves over 225,000 patients annually, primarily delivering continuous glucose monitors. Strive serves more than 20,000 customers yearly, specialising in urology, wound care and incontinence supplies.

PR Newswire
Jan 31st, 2024
Cardinal Health To Acquire Specialty Networks And Its Pps Analytics Platform, A Technology Enabled Multi-Specialty Group Purchasing And Practice Enhancement Organization In Urology, Rheumatology And Gastroenterology

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices. Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas. Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ NetworkDUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for $1.2B in cash. Specialty Networks creates clinical and economic value for independent specialty providers and partners across multiple specialty GPOs: UroGPO, Gastrologix and GastroGPO, and United Rheumatology

Intelligence360 News
Mar 7th, 2023
Cardinal Health To Spend $3,100,000.00 To Occupy 3,794 Square Feet Of Space In Indianapolis Indiana.

Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana. Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana.Indianapolis, Indiana — According to state and local economic development sources, Cardinal Health plans to invest $3,100,000.00 to build out 3,794 square feet of new space in Indianapolis. The company plans to occupy the new space at 7736 Zionsville Rd in Indianapolis, on or about September 1, 2023. According to the company website Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world

GlobeNewswire
Jul 26th, 2022
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients

Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem...